Tci Wealth Advisors, Inc. Omeros Corp Transaction History

Tci Wealth Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$1.75 - $3.96 $175 - $396	-100 Reduced 33.33%	200 $0
Q1 2022 Apr 29, 2022	BUY	$5.07 - $7.2 $507 - $720	100 Added 50.0%	300 $2,000
Q4 2021 Jan 24, 2022	SELL	$5.67 - $8.54 $618 - $930	-109 Reduced 35.28%	200 $1,000
Q3 2021 Oct 29, 2021	BUY	$13.4 - $16.3 $2,800 - $3,406	209 Added 209.0%	309 $4,000
Q2 2021 Aug 02, 2021	SELL	$14.81 - $19.13 $2,947 - $3,806	-199 Reduced 66.56%	100 $1,000
Q1 2021 Apr 29, 2021	BUY	$14.52 - $23.53 $1,437 - $2,329	99 Added 49.5%	299 $5,000
Q3 2020 Oct 20, 2020	BUY	$9.57 - $21.32 $957 - $2,132	100 Added 100.0%	200 $2,000
Q3 2019 Oct 17, 2019	SELL	$14.55 - $20.56 $1,455 - $2,056	-100 Reduced 50.0%	100 $2,000
Q1 2019 Apr 11, 2019	SELL	$11.65 - $17.72 $1,165 - $1,772	-100 Reduced 33.33%	200 $3,000
Q4 2018 Jan 17, 2019	BUY	$10.72 - $16.73 $3,216 - $5,019	300 New	300 $3,000
Q1 2018 Apr 30, 2018	SELL	$9.0 - $20.16 $900 - $2,016	-100 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$13.26 - $22.86 $1,326 - $2,286	100	100 $2,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.